Synairgen plc (SYGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 9, 2026
Synairgen Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.53 | 4.55 | 10.52 | 15.93 | 33.83 |
Short-Term Investments | - | - | 1.5 | 3.75 | - |
Cash & Short-Term Investments | 12.53 | 4.55 | 12.02 | 19.68 | 33.83 |
Cash Growth | 175.19% | -62.10% | -38.93% | -41.83% | -54.88% |
Other Receivables | 1.23 | 2.55 | 1.48 | 2.65 | 9.61 |
Receivables | 1.23 | 2.55 | 1.48 | 2.65 | 9.61 |
Prepaid Expenses | 0.79 | 0.52 | 0.59 | 1.07 | 0.97 |
Total Current Assets | 14.55 | 7.62 | 14.09 | 23.4 | 44.41 |
Property, Plant & Equipment | 0.05 | 0.1 | 0.03 | 0.09 | 0.17 |
Other Intangible Assets | 0.02 | 0.1 | 0.1 | 0.04 | 0.05 |
Total Assets | 14.62 | 7.82 | 14.22 | 23.53 | 44.64 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.31 | 0.76 | 0.59 | 0.55 | 4.16 |
Accrued Expenses | 1.22 | 0.78 | 0.97 | 2.71 | 3.48 |
Total Current Liabilities | 2.53 | 1.54 | 1.56 | 3.25 | 7.64 |
Total Liabilities | 2.53 | 1.54 | 1.56 | 3.25 | 7.64 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 11.03 | 2.03 | 2.01 | 2.01 | 2.01 |
Additional Paid-In Capital | 134.14 | 125.25 | 125.25 | 125.25 | 125.25 |
Retained Earnings | -133.56 | -121.48 | -115.09 | -107.47 | -90.74 |
Comprehensive Income & Other | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
Shareholders' Equity | 12.09 | 6.28 | 12.66 | 20.28 | 37 |
Total Liabilities & Equity | 14.62 | 7.82 | 14.22 | 23.53 | 44.64 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 12.53 | 4.55 | 12.02 | 19.68 | 33.83 |
Net Cash Growth | 175.19% | -62.10% | -38.93% | -41.83% | -54.81% |
Net Cash Per Share | 0.01 | 0.02 | 0.06 | 0.10 | 0.17 |
Filing Date Shares Outstanding | 1,103 | 202.66 | 201.37 | 201.37 | 201.34 |
Total Common Shares Outstanding | 1,103 | 202.66 | 201.37 | 201.37 | 201.34 |
Working Capital | 12.03 | 6.08 | 12.53 | 20.15 | 36.77 |
Book Value Per Share | 0.01 | 0.03 | 0.06 | 0.10 | 0.18 |
Tangible Book Value | 12.08 | 6.18 | 12.56 | 20.23 | 36.95 |
Tangible Book Value Per Share | 0.01 | 0.03 | 0.06 | 0.10 | 0.18 |
Machinery | 0.95 | 0.74 | 0.65 | 0.63 | 0.63 |